Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Statistical analysis of cost outcomes in a randomized controlled clinical trial.
Rutten-van Mölken MP, van Doorslaer EK, van Vliet RC. Rutten-van Mölken MP, et al. Health Econ. 1994 Sep-Oct;3(5):333-45. doi: 10.1002/hec.4730030507. Health Econ. 1994. PMID: 7827649
Methodological issues of patient utility measurement. Experience from two clinical trials.
Rutten-van Mölken MP, Bakker CH, van Doorslaer EK, van der Linden S. Rutten-van Mölken MP, et al. Med Care. 1995 Sep;33(9):922-37. doi: 10.1097/00005650-199509000-00004. Med Care. 1995. PMID: 7666706 Clinical Trial.
Costs and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease.
Rutten-van Mölken MP, Van Doorslaer EK, Jansen MC, Kerstjens HA, Rutten FF. Rutten-van Mölken MP, et al. Am J Respir Crit Care Med. 1995 Apr;151(4):975-82. doi: 10.1164/ajrccm.151.4.7697275. Am J Respir Crit Care Med. 1995. PMID: 7697275 Clinical Trial.
Health economic assessment of behavioural rehabilitation in chronic low back pain: a randomised clinical trial.
Goossens ME, Rutten-Van Mölken MP, Kole-Snijders AM, Vlaeyen JW, Van Breukelen G, Leidl R. Goossens ME, et al. Health Econ. 1998 Feb;7(1):39-51. doi: 10.1002/(sici)1099-1050(199802)7:1<39::aid-hec323>3.0.co;2-s. Health Econ. 1998. PMID: 9541083 Clinical Trial.
Association between health-related quality of life and consultation for respiratory symptoms: results from the DIMCA programme.
van den Boom G, Rutten-van Mölken MP, Tirimanna PR, van Schayck CP, Folgering H, van Weel C. van den Boom G, et al. Eur Respir J. 1998 Jan;11(1):67-72. doi: 10.1183/09031936.98.11010067. Eur Respir J. 1998. PMID: 9543272
Cost effectiveness of inhaled corticosteroid plus bronchodilator therapy versus bronchodilator monotherapy in children with asthma.
Rutten-van Mölken MP, Van Doorslaer EK, Jansen MC, Van Essen-Zandvliet EE, Rutten FF. Rutten-van Mölken MP, et al. Pharmacoeconomics. 1993 Oct;4(4):257-70. doi: 10.2165/00019053-199304040-00004. Pharmacoeconomics. 1993. PMID: 10146915
Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.
Rutten-van Mölken MP, van Doorslaer EK, Till MD. Rutten-van Mölken MP, et al. Pharmacoeconomics. 1998 Dec;14(6):671-84. doi: 10.2165/00019053-199814060-00007. Pharmacoeconomics. 1998. PMID: 10346418 Clinical Trial.
130 results
Jump to page
Feedback